COVID, Colons and Collective Action: What’s New for Health and Health Care in the U.S. and Globally
Thomas R. Frieden, MD, MPH

Symposium 1A: ACG Past Presidents’ Symposium

Moderator: Sunanda V. Kane, MD, MSPH, FACG

• Intestinal Dysbiosis and Recurrent C. difficile: Impact and Clinical Solutions
  Past President: Christina M. Surawicz, MD, MACG
  Jessica R. Allegretti, MD, MPH
  Discuss and apply emerging therapeutic options for dysbiosis and recurrent C. difficile.
• New Technologies in GERD and How to Use Them in the Clinical Setting
  Past President: Joel E. Richter, MD, MACG
  Marcelo F. Vela, MD, MSCR, FACG
  Recognize evolving technologies in GERD and how to use them in the clinical setting.
• Improving Access, Acceptability, Quality, and Cost-Effectiveness of Colon Cancer Screening
  Past President: Mark B. Pochapin, MD, FACG
  John M. Inadomi, MD, FACG
  Appraise and apply contemporary best evidence in the management of colon cancer screening.

Symposium 1B: Complications of Advanced Liver Disease
Moderator: Norah A. Terrault, MD, MPH, FACG

• Updates in Current Management of Ascites, SBP, and HRS
  Jasmohan S. Bajaj, MD, MSc, FACG
  Discuss best practices in the evaluation of abdominal ascites, spontaneous bacterial peritonitis, and acute kidney injury in patients with liver cirrhosis, and apply current evidence-based guideline recommendations.
• Update in Liver Transplantation: Implications for the GI Provider
  Norah A. Terrault, MD, MPH, FACG
  Summarize new UNOS policies governing organ allocation for liver transplantation, and outline evidence-based recommendations for the general gastroenterologist caring for patients both pre- and post-transplantation.
• Current Concepts in the Management of Hepatic Encephalopathy
  R. Todd Frederick, MD
  Review current and evolving guidelines for the diagnosis and management of occult and overt hepatic encephalopathy.

Symposium 1C: Update on Endoscopic Resection of Colorectal Lesions
Moderator: Tonya R. Kaltenbach, MD, MS, FACG

• Optical Diagnosis of Benign and Malignant Colorectal Lesions
  Sarah K. McGill, MD
  Identify the signature features of benign and malignant colorectal lesions and apply classifications to enhance real-time histologic prediction of lesions.
• Cold Snare Polypectomy for Complete Removal of Small Colorectal Lesions
  Swati G. Patel, MD
  Discuss the updated USMSTF recommendations on optimal polypectomy techniques for small colorectal lesions.
• EMR of Large Colorectal Lesions
  Tonya R. Kaltenbach, MD, MS, FACG
  Describe the techniques for endoscopic mucosal resection of large colon polyps, and identify best practices including when to refer to a specialist.
• Prevention and Management of Large Polyp Resection Complications
  Douglas K. Rex, MD, MACG
  Identify methods to prevent and manage complications of large polyp resection.
• Quality and Competency in Colorectal Lesion Removal: Training and Sustaining
  Roy M. Soetikno, MD, FACG
  Summarize competency learning curves and optimal training strategies for colorectal lesion removal, including simulation-based learning.

Hidden in Plain Sight: Bringing Women Into the Scope of Gastroenterology
Presenter: Amy S. Oxentenko, MD, FACG
Introduced by: Brian E. Lacy, MD, PhD, FACG, and Brennan M. Spiegel, MD, MSHS, FACG
Detail the impact of women in the course of history of medicine and gastroenterology.

Symposium 2A: Starting, Switching, and Stopping Therapy in IBD
Moderator: Christina Y. Ha, MD, FACG

• Starting Therapy in IBD
  Bincy P. Abraham, MD, FACG
  Summarize treatment strategies for initiating therapy in mild and moderate-severe Crohn’s disease and ulcerative colitis.
• Switching Therapy in IBD
  Raymond K. Cross, MD, MS, FACG
  Decide when to switch within and out of medication class in IBD, including loss of response, immunogenicity, adverse events, and biosimilars.
• Stopping and De-Escalating Therapy in IBD
  Christina Y. Ha, MD, FACG
  Describe a practical approach to de-escalation and monitoring of IBD therapy.

Symposium 2B: ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Moderator: Brian E. Lacy, MD, PhD, FACG

• IBS — Making the Diagnosis
  Brian E. Lacy, MD, PhD, FACG
  Discuss the ACG guideline recommendations for diagnostic testing in irritable bowel syndrome.
• Pharmacotherapy of IBS
  Darren M. Brenner, MD, FACG
  Describe the rationale for ACG guideline recommendations for pharmacologic therapy for irritable bowel syndrome.
• Non-Pharmacologic Treatment Options for IBS
  Baharak Moshiree, MD, MSc
  Interpret the latest ACG guidelines as they relate to the non-pharmacologic management of IBS patients.

Symposium 2C: Live From Las Vegas! The 9th Annual Endoscopy Video Forum

Moderators: Seth A. Gross, MD, FACG, and Vivek Kaul, MD, FACG
Judges: David J. Hass, MD, FACG; Laith H. Jamil, MD, FACG; Pichamol Jirapinyo, MD, MPH; Shivangi T. Kothari, MD, FACG; Saowanee Ngamruengphong, MD; Kevin E. Woods, MD, MPH
Demonstrate interesting endoscopic findings and techniques encountered in daily clinical practice.

Symposium 3A: Updates on CRC Screening and Surveillance
Moderator: Charles J. Kahi, MD, MSc, FACG

• At What Age Should I Start Screening and When Should I Stop?
  Aasma Shaukat, MD, MPH, FACG
  Review the evidence of more aggressive, earlier colorectal cancers to support clinical guidelines for screening.
• How to Inform Patient Screening Choice in the Context of COVID
  Charles J. Kahi, MD, MSc, FACG
  Define screening test characteristic performances for adenoma, advanced adenoma, and cancer by stage; and highlight shifts, barriers, and facilitators to high-quality screening during a pandemic.
• How to Incorporate the New CRC Surveillance Recommendations Into Practice
  Samir Gupta, MD
  Summarize post-polypectomy surveillance recommendations, including major changes from the prior recommendations, and outline evidence-based surveillance practices.

Symposium 3B: The Latest in the A-Zs of Acute Pancreatitis
Moderator: Linda S. Lee, MD

• Managing Acute Pancreatitis in the First 24 Hours
  Bechien U. Wu, MD
  Explain how to diagnose and risk stratify patients with acute pancreatitis, and identify key components in early management including fluids, diet, pain control, antibiotic use, and monitoring for compartment syndrome.
• Managing Complications of Acute Pancreatitis Including Leaks and Collections
  Linda S. Lee, MD
  Describe common complications of acute pancreatitis that can be managed endoscopically, including pseudocysts, walled-off necrosis and pancreatic duct leaks, and recognize optimal treatment approaches for these conditions.
• Idiopathic Recurrent Acute Pancreatitis: How to Evaluate and Manage
  Darwin L. Conwell, MD, MS, FACG
  Discuss work-up for diagnosing the etiology of idiopathic recurrent acute pancreatitis, and outline medical and endoscopic management.

Symposium 3C: Gastric Disorders: Burning Issues in 2021
Moderator: Colin W. Howden, MD, FACG

• Acid-Peptic Disorders: What’s New in 2021?
  Colin W. Howden, MD, FACG
  Identify new therapeutic options for acid-peptic disorders.
• Update in Gastroparesis and Functional Dyspepsia
  Braden Kuo, MD
  Explain medical and surgical therapies for motility and functional disorders of the stomach.
• Polyps and Nodules of the Stomach: When to Survey, Resect, or Refer for EUS
  Saowanee Ngamruengphong, MD
  Summarize the latest diagnostic and management approaches to polyps and nodules of the stomach.

Changing the Narrative on Colorectal Cancer Prevention: Translating Stories to Partnership, Policy, and Practice
Presenter: Darrell M. Gray, II, MD, MPH, FACG
Introduced by: David A. Greenwald, MD, FACG
Identify opportunities to enhance CRC screening uptake and improve CRC outcomes in diverse communities.

Symposium 4A: Functional Esophageal Disorders: Managing Patients With Symptoms and Negative Testing
Moderator: Ronnie Fass, MD, FACG

• Functional Heartburn
  Ronnie Fass, MD, FACG
  Discuss the diagnosis of functional heartburn and options for management.
• Functional Chest Pain
  John O. Clarke, MD, FACG
  Review the approach to evaluation of non-cardiac chest pain, and the management of patients with chest pain and negative testing.
• Functional Dysphagia
  Charlene Prather, MD, MPH
  Describe the diagnostic approach and treatment options for functional dysphagia.

Symposium 4B: Conundrums of Pancreatobiliary Diseases
Moderator: Linda S. Lee, MD

• How Do I Get the Large Biliary Stone Out?
  Harry R. Aslanian, MD, FACG
  Describe how best to remove large biliary stones while minimizing risk of perforation and pancreatitis.
• Pancreatic Cyst Management 101
  Linda S. Lee, MD
  Discuss the different guidelines and how to approach pancreatic cyst management.
• 2021 Updates in Diagnosing and Managing Biliary Strictures: Is It Malignant or Not? Stent Both Sides or Not?
  Phillip S. Ge, MD
  Explain the advances in diagnosing indeterminate biliary strictures utilizing conventional techniques, FISH, DNA analysis, cholangioscopy, nCLE, and artificial intelligence; discuss how best to manage suspected hilar cholangiocarcinoma while avoiding potential pitfalls.

Navigating the Road From Precision to Prevention in IBD
Presenter: Marla C. Dubinsky, MD
Introduced by: David A. Greenwald, MD, FACG
Discuss biomarkers for monitoring inflammation, using prognostic factors to guide IBD therapy, and explain the preclinical phase of IBD.

Symposium 5A: Fecal Microbiota Transplantation at a Crossroads: Where Are We Now and Where Are We Going?
Moderator: Paul Feuerstadt, MD, FACG

• A Clinician’s Crash Course to Understanding the Microbiota
  Paul Feuerstadt, MD, FACG
  Review what the microbiota is and how it is measured and evaluated, recognize what a “normal” microbiota consortium looks like, and define the most common terms used in this field.
• The Future of Microbiota Restoration in C. difficile Infections
  Sahil Khanna, MD, FACG
  Identify the newest investigational microbiota replacement therapy products used to treat C. difficile infection.
• Microbiota Restoration in Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Liver Disease
  Olga C. Aroniadis, MD, MSc
  Describe the alterations in the microbiota seen in non-C. difficile infection gastrointestinal diseases, and explain what the next 1-2 years of research might look like with regard to applying microbiota therapy to these disease states.

Symposium 5B: Recent Developments in Esophageal Motility Disorders
Moderator: Katarina B. Greer, MD, MS Epi

• Achalasia Guideline: Breaking It Down – Diagnosis, Pearls, Subtype, Management
  Katarina B. Greer, MD, MS Epi
  Discuss the common subtypes of achalasia, diagnosis and best management strategies, and how to manage treatment failures.
• The New Chicago Classification Version 4.0: Implications for Clinical Practice
  John E. Pandolfino, MD, MSCI, FACG
  Review the new Chicago classification of esophageal motility disorders and discuss its implications for clinical practice.
• EGJOO and Opioid-Induced Esophageal Dysfunction: Extra Considerations in Diagnosis, Treatment, and Management
  Marcelo F. Vela, MD, MSCR, FACG
  Describe esophagogastric junction outflow obstruction diagnosis, differential diagnosis, and management options.